Basics Pliant Therapeutics, Inc. IPO Date: June 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $114.18M Activated in VL: True Average Daily Range Avg Daily Range: $0.55 | 3.20% Avg Daily Range (30 D): $0.06 | 4.08% Avg Daily Range (90 D): $0.05 | 3.77% Institutional Daily Volume Avg Daily Volume: .52M Avg Daily Volume (30 D): .87M Avg Daily Volume (90 D): .93M Trade Size Avg Trade Size (Sh.): 93 Avg Trade Size (Sh.) (30 D): 189 Avg Trade Size (Sh.) (90 D): 179 Institutional Trades Total Inst.Trades: 1,071 Avg Inst. Trade: $1.51M Avg Inst. Trade (30 D): $1.63M Avg Inst. Trade (90 D): $2.01M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.58M Avg Closing Trade (30 D): $6.05M Avg Closing Trade (90 D): $4.04M Avg Closing Volume: 100.94K     News Mar 23, 2025 @ 12:34 PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates ... Source: N/A Feb 7, 2025 @ 9:58 PM Pliant Therapeutics Provides Update on BEACON-IPF,... Source: N/A Nov 18, 2024 @ 11:00 PM Pliant Therapeutics Presents Data from its Bexoteg... Source: N/A Jul 13, 2024 @ 1:35 AM Pliant Therapeutics CBO sells shares worth over $1... Source: Investing.Com May 7, 2024 @ 3:53 PM These Analysts Revise Their Forecasts On Pliant Th... Source: Avi Kapoor Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.71 $-.92 Diluted EPS $-.71 $-.92 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -43.3M $ -56.17M Operating Income / Loss $ $ -45.59M $ -58.94M Cost of Revenue $ $ $ Net Cash Flow $ $ -5.12M $ 20.75M PE Ratio